{"id":350782,"date":"2025-08-25T19:56:44","date_gmt":"2025-08-25T19:56:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-penumbra\/"},"modified":"2025-08-25T19:56:44","modified_gmt":"2025-08-25T19:56:44","slug":"how-to-buy-penumbra","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/","title":{"rendered":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350782","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Penumbra, Inc. (PEN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve bu medikal cihaz liderinin 2025 y\u0131l\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme kataliz\u00f6rleri ve yenilik\u00e7i teknolojisiyle neden cazip yat\u0131r\u0131m f\u0131rsatlar\u0131 sundu\u011funu ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Penumbra, Inc. (PEN) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin ve bu medikal cihaz liderinin 2025 y\u0131l\u0131nda g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme kataliz\u00f6rleri ve yenilik\u00e7i teknolojisiyle neden cazip yat\u0131r\u0131m f\u0131rsatlar\u0131 sundu\u011funu ke\u015ffedin."},"intro":"Keskin medikal teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Penumbra, Inc. (PEN), minimal invaziv vask\u00fcler tedavilerin gelece\u011fini temsil ediyor - ve portf\u00f6y\u00fcn\u00fcz bu patlay\u0131c\u0131 b\u00fcy\u00fcmeden fayda sa\u011flayabilir. Bu yenilik\u00e7i \u015firket, inme ve pulmoner emboli tedavilerinde devrim yarat\u0131rken etkileyici finansal sonu\u00e7lar sunuyor. PEN'in neden dikkatinizi hak etti\u011fini ve nas\u0131l hissedar olabilece\u011finizi birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Keskin medikal teknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Penumbra, Inc. (PEN), minimal invaziv vask\u00fcler tedavilerin gelece\u011fini temsil ediyor - ve portf\u00f6y\u00fcn\u00fcz bu patlay\u0131c\u0131 b\u00fcy\u00fcmeden fayda sa\u011flayabilir. Bu yenilik\u00e7i \u015firket, inme ve pulmoner emboli tedavilerinde devrim yarat\u0131rken etkileyici finansal sonu\u00e7lar sunuyor. PEN'in neden dikkatinizi hak etti\u011fini ve nas\u0131l hissedar olabilece\u011finizi birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Penumbra Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla Penumbra, Inc. (PEN) NYSE'de <strong>264,67 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu medikal cihaz yenilik\u00e7isi, hayat kurtaran ve \u00f6nemli hissedar de\u011feri yaratan \u00e7\u0131\u011f\u0131r a\u00e7an trombektomi teknolojileriyle dikkat \u00e7ekiyor.<\/p> <p><strong>Takviminize Not Edin: 29 Ekim 2025<\/strong> - PEN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in bu y\u0131l\u0131n en \u00f6nemli tarihi bu. \u015eirketin 2025 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn ve ge\u00e7mi\u015fte bu t\u00fcr a\u00e7\u0131klamalar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebiliyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 PEN Hissesini Nas\u0131l Etkiler?<\/h3> <p>Son performans \u00f6r\u00fcnt\u00fcleri, yat\u0131r\u0131m zamanlamas\u0131 i\u00e7in kritik bilgiler sunuyor:<\/p> <table> <thead> <tr> <th>Tarih<\/th> <th>Olay<\/th> <th>Haber \u00d6ncesi Fiyat<\/th> <th>Haber Sonras\u0131 De\u011fi\u015fim<\/th> <th>Analiz<\/th> <\/tr> <\/thead> <tbody> <tr> <td>29 Temmuz 2025<\/td> <td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>255,50 $<\/td> <td>%3,6 Art\u0131\u015f (1 hafta)<\/td> <td>339,5M $ gelirle tahminleri a\u015ft\u0131<\/td> <\/tr> <tr> <td>23 Nisan 2025<\/td> <td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>240,80 $<\/td> <td>%5,2 Art\u0131\u015f (3 g\u00fcn)<\/td> <td>%16,3 gelir art\u0131\u015f\u0131 piyasalar\u0131 etkiledi<\/td> <\/tr> <tr> <td>\u015eubat 2025<\/td> <td>\u00dcr\u00fcn Lansman\u0131<\/td> <td>225,60 $<\/td> <td>%11,6 Art\u0131\u015f (s\u0131\u00e7rama)<\/td> <td>Ruby XL sistemi heyecan\u0131<\/td> <\/tr> <tr> <td>Ekim 2024<\/td> <td>3. \u00c7eyrek 2024<\/td> <td>218,40 $<\/td> <td>%4,8 Art\u0131\u015f<\/td> <td>G\u00fc\u00e7l\u00fc rehberlik art\u0131\u015f\u0131<\/td> <\/tr> <tr> <td>Temmuz 2024<\/td> <td>2. \u00c7eyrek 2024<\/td> <td>210,20 $<\/td> <td>%3,1 Art\u0131\u015f<\/td> <td>\u0130stikrarl\u0131 b\u00fcy\u00fcme e\u011filimi<\/td> <\/tr> <\/tbody> <\/table> <p><strong>E\u011filim Analizi<\/strong>: PEN genellikle g\u00fc\u00e7l\u00fc kazan\u00e7 a\u00e7\u0131klamalar\u0131ndan sonra %3-6 aras\u0131nda pozitif hareketler ya\u015far, \u00fcr\u00fcn lansmanlar\u0131 ise daha b\u00fcy\u00fck s\u0131\u00e7ramalar yarat\u0131r. Bu \u00f6r\u00fcnt\u00fc, uygulamalar\u0131na inan\u0131yorsan\u0131z kazan\u00e7 \u00f6ncesi al\u0131m yapman\u0131n karl\u0131 olabilece\u011fini g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u015eubat - A\u011fustos 2025<\/h2> <p>Penumbra hisseleri son alt\u0131 ayda etkileyici bir <strong>%17,8 getiri<\/strong> sa\u011flad\u0131 ve medikal cihaz sekt\u00f6r\u00fc ile genel piyasa endekslerinin olduk\u00e7a \u00fczerinde performans g\u00f6sterdi.<\/p> <p><strong>Ayl\u0131k Da\u011f\u0131l\u0131m:<\/strong><\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: 225,60 $ (tatil sonras\u0131 konsolidasyon)<\/li> <li><strong>Mart 2025<\/strong>: 238,90 $ (1. \u00e7eyrek kazan\u00e7 beklentisi art\u0131\u015f\u0131)<\/li> <li><strong>Nisan 2025<\/strong>: 253,20 $ (kazan\u00e7 sonras\u0131 s\u0131\u00e7rama +%16,3 gelir art\u0131\u015f\u0131)<\/li> <li><strong>May\u0131s 2025<\/strong>: 261,80 $ (Ruby XL FDA onay\u0131 heyecan\u0131)<\/li> <li><strong>Haziran 2025<\/strong>: 272,40 $ (yaz rallisi ivmesi)<\/li> <li><strong>Temmuz 2025<\/strong>: 268,10 $ (2. \u00e7eyrek kazan\u00e7 konsolidasyonu)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 264,67 $ (tipik yaz volatilitesi)<\/li> <\/ul> <p><strong>G\u00fc\u00e7l\u00fc Performans\u0131n Nedenleri?<\/strong><\/p> <ul> <li>ABD trombektomi gelirleri y\u0131ll\u0131k %25 b\u00fcy\u00fcd\u00fc<\/li> <li>Br\u00fct kar marjlar\u0131 ola\u011fan\u00fcst\u00fc %66 seviyesinde<\/li> <li>S\u0131f\u0131r bor\u00e7lu bilan\u00e7o finansal esneklik sa\u011fl\u0131yor<\/li> <li>2025 boyunca bir\u00e7ok ba\u015far\u0131l\u0131 \u00fcr\u00fcn lansman\u0131<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve b\u00fcy\u00fcme e\u011filimine g\u00f6re beklentiler:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 295-310 $ (mevcut seviyelerden %13-18 y\u00fckseli\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br> <em>Gerek\u00e7e: 4. \u00e7eyrek mevsimsel g\u00fc\u00e7 + rehberlikte devam eden ba\u015far\u0131<\/em><\/li> <li><strong>2026 Tahmini<\/strong>: 340-375 $ (%28-42 b\u00fcy\u00fcme potansiyeli)<br> <em>Kataliz\u00f6rler: Ruby XL tam ticarile\u015fmesi + uluslararas\u0131 geni\u015fleme<\/em><\/li> <li><strong>2028 Projeksiyonu<\/strong>: 450-500 $ (%70-89 de\u011fer art\u0131\u015f\u0131 potansiyeli)<br> <em>\u0130tici G\u00fc\u00e7ler: Pazar pay\u0131 kazan\u0131mlar\u0131 + yeni \u00fcr\u00fcn kategorileri<\/em><\/li> <li><strong>2030 Vizyonu<\/strong>: 600 $+ (%125+ uzun vadeli getiri)<br> <em>Temel: Ya\u015flanan n\u00fcfus talebi + teknoloji liderli\u011fi<\/em><\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: PEN, bir\u00e7ok k\u0131sa vadeli kataliz\u00f6rle cazip bir uzun vadeli b\u00fcy\u00fcme hikayesi sunuyor. Risk-getiri profili, piyasa zay\u0131fl\u0131klar\u0131nda al\u0131m yapmay\u0131 destekliyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onay s\u00fcre\u00e7leri \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir (<a href=\"https:\/\/dcfmodeling.com\/products\/pen-pestel-analysis\">y\u0131ll\u0131k 12,4M $ uyum maliyeti<\/a>)<\/li> <li><strong>Volatilite Riski<\/strong>: %2,09 ortalama g\u00fcnl\u00fck volatilite g\u00fc\u00e7l\u00fc bir dayan\u0131kl\u0131l\u0131k gerektirir<\/li> <li><strong>Rekabetin Artmas\u0131<\/strong>: B\u00fcy\u00fck medikal teknoloji oyuncular\u0131n\u0131n trombektomi alan\u0131na giri\u015fi<\/li> <li><strong>\u0130\u00e7erden Sat\u0131\u015flar<\/strong>: CEO 2025'te 4M $+ hisse satt\u0131 (<a href=\"https:\/\/www.ainvest.com\/news\/insider-selling-penumbra-liquidity-event-early-warning-signal-2508\/\">rutin ama izlenmeli<\/a>)<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme<\/strong>: ABD trombektomi gelirleri y\u0131ll\u0131k %25 artt\u0131 (<a href=\"https:\/\/www.penumbrainc.com\/penumbra-inc-reports-first-quarter-2025-financial-results\/\">2025 1. \u00e7eyrek sonu\u00e7lar\u0131<\/a>)<\/li> <li><strong>\u00dcr\u00fcn \u0130novasyonu<\/strong>: Ruby XL sistemi Haziran 2025'te piyasaya s\u00fcr\u00fcld\u00fc (<a href=\"https:\/\/www.penumbrainc.com\/penumbra-introduces-the-ruby-xl-system-the-longest-largest-and-softest-coil-on-the-market-for-vascular-embolization\/\">oyun de\u011fi\u015ftirici teknoloji<\/a>)<\/li> <li><strong>Marj Geni\u015flemesi<\/strong>: %66 br\u00fct kar marjlar\u0131 ve iyile\u015ftirme hedefleri<\/li> <li><strong>Analist Deste\u011fi<\/strong>: 14 Al, 4 Tut, 0 Sat puan\u0131 (<a href=\"https:\/\/www.directorstalkinterviews.com\/penumbra-inc-pen-stock-analysis-22-87-potential-upside-in-medical-device-innovation\/4121212482\">g\u00fc\u00e7l\u00fc konsens\u00fcs<\/a>)<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Rahat uyuyabilece\u011finiz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n - 500 $ bile kesirli hisse ile ba\u015flamak i\u00e7in yeterlidir<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Haftal\u0131k\/ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yaparak zamanlama hatalar\u0131ndan ka\u00e7\u0131n\u0131n<\/li> <li><strong>Kazan\u00e7 Uyar\u0131lar\u0131 Kurun<\/strong>: 29 Ekim'i i\u015faretleyin ve kazan\u00e7 sonras\u0131 hareketlere haz\u0131r olun<\/li> <li><strong>Ak\u0131ll\u0131ca \u00c7e\u015fitlendirin<\/strong>: PEN'i toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %10'unun alt\u0131nda tutarak risk y\u00f6netimi sa\u011flay\u0131n<\/li> <\/ol> <p><strong>Esprili deneyimli tavsiye<\/strong>: \"PEN ticareti, medikal cihazlar\u0131 gibi - i\u015flem s\u0131ras\u0131nda panik yapmad\u0131\u011f\u0131n\u0131zda en iyi sonucu verir. Sab\u0131rl\u0131 eller en iyi sonu\u00e7lar\u0131 al\u0131r!\"<\/p> <h2>\u2705 Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir Ticaret Platformu Se\u00e7in<\/td> <td>NYSE eri\u015fimi ve kesirli hisse sunan bir platform se\u00e7in<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td> <td>Rahat hissetti\u011finiz herhangi bir miktarla ba\u015flay\u0131n<\/td> <\/tr> <tr> <td>3<\/td> <td>\"PEN\" Ticker'\u0131n\u0131 Aray\u0131n<\/td> <td>Sadece \"Penumbra\" de\u011fil, tam sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>4<\/td> <td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td> <td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>\u0130nceleyin ve Onaylay\u0131n<\/td> <td>Komisyon \u00fccretlerini kontrol edin - %0,5'in alt\u0131nda hedefleyin<\/td> <\/tr> <tr> <td>6<\/td> <td>Pozisyonunuzu Takip Edin<\/td> <td>Kazan\u00e7 tarihleri i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td> <\/tr> <tr> <td>7<\/td> <td>Temett\u00fcleri Yeniden Yat\u0131r\u0131n<\/td> <td>PEN hen\u00fcz temett\u00fc \u00f6demiyor, ancak b\u00fcy\u00fcme planlay\u0131n<\/td> <\/tr> <tr> <td>8<\/td> <td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td> <td>Kazan\u00e7 raporlar\u0131 ve rehberlik g\u00fcncellemelerini takip edin<\/td> <\/tr> <tr> <td>9<\/td> <td>Stratejinizi Ayarlay\u0131n<\/td> <td>Performans ve piyasa ko\u015fullar\u0131na g\u00f6re<\/td> <\/tr> <tr> <td>10<\/td> <td>Uzun Vadeli Perspektif<\/td> <td>Medikal cihaz yat\u0131r\u0131m\u0131 sab\u0131r gerektirir<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Penumbra hisselerini eri\u015filebilir k\u0131lan birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile ger\u00e7ek piyasa maruziyetiyle stratejileri test etmeye ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: 1 dakikal\u0131k KYC s\u00fcreci ile herhangi bir resmi kimlik kullanarak hemen i\u015flem yapabilirsiniz<\/li> <li><strong>\u00c7ekim Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>Kesirli Hisseler<\/strong>: PEN gibi premium hisselerde pozisyonlar\u0131 kademeli olarak olu\u015fturmak i\u00e7in ideal<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, b\u00fcy\u00fck sermaye gerektirmeden Penumbra gibi yenilik\u00e7i \u015firketlere yat\u0131r\u0131m yapmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d Penumbra 2025'te: Medikal Teknoloji Lideri<\/h2> <p>Penumbra, inme ve pulmoner emboliye neden olan kan p\u0131ht\u0131lar\u0131n\u0131 \u00e7\u0131karan cihazlarda uzmanla\u015fm\u0131\u015f vask\u00fcler m\u00fcdahale teknolojilerinde \u00f6nc\u00fc konumdad\u0131r. \u015eirketin \u00fcr\u00fcnleri d\u00fcnya \u00e7ap\u0131nda 1.400'den fazla hastanede kullan\u0131lmakta ve 500.000'den fazla hastaya tedavi sa\u011flam\u0131\u015ft\u0131r.<\/p> <p><strong>Mevcut Pazar Konumu<\/strong>:<\/p> <ul> <li>Mekanik trombektomi cihazlar\u0131nda lider<\/li> <li>1,34 milyar $ y\u0131ll\u0131k gelir h\u0131z\u0131<\/li> <li>%66 br\u00fct kar marjlar\u0131 ile fiyatlama g\u00fcc\u00fc<\/li> <li>S\u0131f\u0131r bor\u00e7 ve g\u00fc\u00e7l\u00fc nakit pozisyonu<\/li> <\/ul> <p><strong>2025 \u0130novasyon Odaklar\u0131<\/strong>:<\/p> <ul> <li>Ruby XL embolizasyon sisteminin geni\u015fletilmesi<\/li> <li>VTE (ven\u00f6z tromboembolizm) platform b\u00fcy\u00fcmesi<\/li> <li>Uluslararas\u0131 pazar penetrasyonu<\/li> <li>Rehber de\u011fi\u015fiklikleri i\u00e7in klinik veri \u00fcretimi<\/li> <\/ul> <p><strong>\u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Penumbra'n\u0131n Lightning Flash\u2122 sistemi, hayat\u0131 tehdit eden kan p\u0131ht\u0131lar\u0131n\u0131 10 dakikadan k\u0131sa s\u00fcrede \u00e7\u0131karabilir - sabah kahvenizi demlemekten daha h\u0131zl\u0131! Bu zaman kazand\u0131ran \u00f6zellik, acil inme bak\u0131m\u0131nda d\u00fcnya \u00e7ap\u0131nda devrim yarat\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Penumbra Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla Penumbra, Inc. (PEN) NYSE&#8217;de <strong>264,67 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu medikal cihaz yenilik\u00e7isi, hayat kurtaran ve \u00f6nemli hissedar de\u011feri yaratan \u00e7\u0131\u011f\u0131r a\u00e7an trombektomi teknolojileriyle dikkat \u00e7ekiyor.<\/p>\n<p><strong>Takviminize Not Edin: 29 Ekim 2025<\/strong> &#8211; PEN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in bu y\u0131l\u0131n en \u00f6nemli tarihi bu. \u015eirketin 2025 3. \u00e7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn ve ge\u00e7mi\u015fte bu t\u00fcr a\u00e7\u0131klamalar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebiliyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 PEN Hissesini Nas\u0131l Etkiler?<\/h3>\n<p>Son performans \u00f6r\u00fcnt\u00fcleri, yat\u0131r\u0131m zamanlamas\u0131 i\u00e7in kritik bilgiler sunuyor:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<th>Analiz<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>29 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>255,50 $<\/td>\n<td>%3,6 Art\u0131\u015f (1 hafta)<\/td>\n<td>339,5M $ gelirle tahminleri a\u015ft\u0131<\/td>\n<\/tr>\n<tr>\n<td>23 Nisan 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>240,80 $<\/td>\n<td>%5,2 Art\u0131\u015f (3 g\u00fcn)<\/td>\n<td>%16,3 gelir art\u0131\u015f\u0131 piyasalar\u0131 etkiledi<\/td>\n<\/tr>\n<tr>\n<td>\u015eubat 2025<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>225,60 $<\/td>\n<td>%11,6 Art\u0131\u015f (s\u0131\u00e7rama)<\/td>\n<td>Ruby XL sistemi heyecan\u0131<\/td>\n<\/tr>\n<tr>\n<td>Ekim 2024<\/td>\n<td>3. \u00c7eyrek 2024<\/td>\n<td>218,40 $<\/td>\n<td>%4,8 Art\u0131\u015f<\/td>\n<td>G\u00fc\u00e7l\u00fc rehberlik art\u0131\u015f\u0131<\/td>\n<\/tr>\n<tr>\n<td>Temmuz 2024<\/td>\n<td>2. \u00c7eyrek 2024<\/td>\n<td>210,20 $<\/td>\n<td>%3,1 Art\u0131\u015f<\/td>\n<td>\u0130stikrarl\u0131 b\u00fcy\u00fcme e\u011filimi<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>E\u011filim Analizi<\/strong>: PEN genellikle g\u00fc\u00e7l\u00fc kazan\u00e7 a\u00e7\u0131klamalar\u0131ndan sonra %3-6 aras\u0131nda pozitif hareketler ya\u015far, \u00fcr\u00fcn lansmanlar\u0131 ise daha b\u00fcy\u00fck s\u0131\u00e7ramalar yarat\u0131r. Bu \u00f6r\u00fcnt\u00fc, uygulamalar\u0131na inan\u0131yorsan\u0131z kazan\u00e7 \u00f6ncesi al\u0131m yapman\u0131n karl\u0131 olabilece\u011fini g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: \u015eubat &#8211; A\u011fustos 2025<\/h2>\n<p>Penumbra hisseleri son alt\u0131 ayda etkileyici bir <strong>%17,8 getiri<\/strong> sa\u011flad\u0131 ve medikal cihaz sekt\u00f6r\u00fc ile genel piyasa endekslerinin olduk\u00e7a \u00fczerinde performans g\u00f6sterdi.<\/p>\n<p><strong>Ayl\u0131k Da\u011f\u0131l\u0131m:<\/strong><\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: 225,60 $ (tatil sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Mart 2025<\/strong>: 238,90 $ (1. \u00e7eyrek kazan\u00e7 beklentisi art\u0131\u015f\u0131)<\/li>\n<li><strong>Nisan 2025<\/strong>: 253,20 $ (kazan\u00e7 sonras\u0131 s\u0131\u00e7rama +%16,3 gelir art\u0131\u015f\u0131)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 261,80 $ (Ruby XL FDA onay\u0131 heyecan\u0131)<\/li>\n<li><strong>Haziran 2025<\/strong>: 272,40 $ (yaz rallisi ivmesi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 268,10 $ (2. \u00e7eyrek kazan\u00e7 konsolidasyonu)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 264,67 $ (tipik yaz volatilitesi)<\/li>\n<\/ul>\n<p><strong>G\u00fc\u00e7l\u00fc Performans\u0131n Nedenleri?<\/strong><\/p>\n<ul>\n<li>ABD trombektomi gelirleri y\u0131ll\u0131k %25 b\u00fcy\u00fcd\u00fc<\/li>\n<li>Br\u00fct kar marjlar\u0131 ola\u011fan\u00fcst\u00fc %66 seviyesinde<\/li>\n<li>S\u0131f\u0131r bor\u00e7lu bilan\u00e7o finansal esneklik sa\u011fl\u0131yor<\/li>\n<li>2025 boyunca bir\u00e7ok ba\u015far\u0131l\u0131 \u00fcr\u00fcn lansman\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve b\u00fcy\u00fcme e\u011filimine g\u00f6re beklentiler:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 295-310 $ (mevcut seviyelerden %13-18 y\u00fckseli\u015f) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <em>Gerek\u00e7e: 4. \u00e7eyrek mevsimsel g\u00fc\u00e7 + rehberlikte devam eden ba\u015far\u0131<\/em><\/li>\n<li><strong>2026 Tahmini<\/strong>: 340-375 $ (%28-42 b\u00fcy\u00fcme potansiyeli)<br \/> <em>Kataliz\u00f6rler: Ruby XL tam ticarile\u015fmesi + uluslararas\u0131 geni\u015fleme<\/em><\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 450-500 $ (%70-89 de\u011fer art\u0131\u015f\u0131 potansiyeli)<br \/> <em>\u0130tici G\u00fc\u00e7ler: Pazar pay\u0131 kazan\u0131mlar\u0131 + yeni \u00fcr\u00fcn kategorileri<\/em><\/li>\n<li><strong>2030 Vizyonu<\/strong>: 600 $+ (%125+ uzun vadeli getiri)<br \/> <em>Temel: Ya\u015flanan n\u00fcfus talebi + teknoloji liderli\u011fi<\/em><\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: PEN, bir\u00e7ok k\u0131sa vadeli kataliz\u00f6rle cazip bir uzun vadeli b\u00fcy\u00fcme hikayesi sunuyor. Risk-getiri profili, piyasa zay\u0131fl\u0131klar\u0131nda al\u0131m yapmay\u0131 destekliyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onay s\u00fcre\u00e7leri \u00fcr\u00fcn lansmanlar\u0131n\u0131 geciktirebilir (<a href=\"https:\/\/dcfmodeling.com\/products\/pen-pestel-analysis\">y\u0131ll\u0131k 12,4M $ uyum maliyeti<\/a>)<\/li>\n<li><strong>Volatilite Riski<\/strong>: %2,09 ortalama g\u00fcnl\u00fck volatilite g\u00fc\u00e7l\u00fc bir dayan\u0131kl\u0131l\u0131k gerektirir<\/li>\n<li><strong>Rekabetin Artmas\u0131<\/strong>: B\u00fcy\u00fck medikal teknoloji oyuncular\u0131n\u0131n trombektomi alan\u0131na giri\u015fi<\/li>\n<li><strong>\u0130\u00e7erden Sat\u0131\u015flar<\/strong>: CEO 2025&#8217;te 4M $+ hisse satt\u0131 (<a href=\"https:\/\/www.ainvest.com\/news\/insider-selling-penumbra-liquidity-event-early-warning-signal-2508\/\">rutin ama izlenmeli<\/a>)<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 B\u00fcy\u00fcme<\/strong>: ABD trombektomi gelirleri y\u0131ll\u0131k %25 artt\u0131 (<a href=\"https:\/\/www.penumbrainc.com\/penumbra-inc-reports-first-quarter-2025-financial-results\/\">2025 1. \u00e7eyrek sonu\u00e7lar\u0131<\/a>)<\/li>\n<li><strong>\u00dcr\u00fcn \u0130novasyonu<\/strong>: Ruby XL sistemi Haziran 2025&#8217;te piyasaya s\u00fcr\u00fcld\u00fc (<a href=\"https:\/\/www.penumbrainc.com\/penumbra-introduces-the-ruby-xl-system-the-longest-largest-and-softest-coil-on-the-market-for-vascular-embolization\/\">oyun de\u011fi\u015ftirici teknoloji<\/a>)<\/li>\n<li><strong>Marj Geni\u015flemesi<\/strong>: %66 br\u00fct kar marjlar\u0131 ve iyile\u015ftirme hedefleri<\/li>\n<li><strong>Analist Deste\u011fi<\/strong>: 14 Al, 4 Tut, 0 Sat puan\u0131 (<a href=\"https:\/\/www.directorstalkinterviews.com\/penumbra-inc-pen-stock-analysis-22-87-potential-upside-in-medical-device-innovation\/4121212482\">g\u00fc\u00e7l\u00fc konsens\u00fcs<\/a>)<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Rahat uyuyabilece\u011finiz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n &#8211; 500 $ bile kesirli hisse ile ba\u015flamak i\u00e7in yeterlidir<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Haftal\u0131k\/ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yaparak zamanlama hatalar\u0131ndan ka\u00e7\u0131n\u0131n<\/li>\n<li><strong>Kazan\u00e7 Uyar\u0131lar\u0131 Kurun<\/strong>: 29 Ekim&#8217;i i\u015faretleyin ve kazan\u00e7 sonras\u0131 hareketlere haz\u0131r olun<\/li>\n<li><strong>Ak\u0131ll\u0131ca \u00c7e\u015fitlendirin<\/strong>: PEN&#8217;i toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %10&#8217;unun alt\u0131nda tutarak risk y\u00f6netimi sa\u011flay\u0131n<\/li>\n<\/ol>\n<p><strong>Esprili deneyimli tavsiye<\/strong>: &#8220;PEN ticareti, medikal cihazlar\u0131 gibi &#8211; i\u015flem s\u0131ras\u0131nda panik yapmad\u0131\u011f\u0131n\u0131zda en iyi sonucu verir. Sab\u0131rl\u0131 eller en iyi sonu\u00e7lar\u0131 al\u0131r!&#8221;<\/p>\n<h2>\u2705 Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve kesirli hisse sunan bir platform se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Fonlamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Rahat hissetti\u011finiz herhangi bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;PEN&#8221; Ticker&#8217;\u0131n\u0131 Aray\u0131n<\/td>\n<td>Sadece &#8220;Penumbra&#8221; de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin &#8211; %0,5&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonunuzu Takip Edin<\/td>\n<td>Kazan\u00e7 tarihleri i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Temett\u00fcleri Yeniden Yat\u0131r\u0131n<\/td>\n<td>PEN hen\u00fcz temett\u00fc \u00f6demiyor, ancak b\u00fcy\u00fcme planlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u00c7eyreklik \u0130nceleme Yap\u0131n<\/td>\n<td>Kazan\u00e7 raporlar\u0131 ve rehberlik g\u00fcncellemelerini takip edin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Stratejinizi Ayarlay\u0131n<\/td>\n<td>Performans ve piyasa ko\u015fullar\u0131na g\u00f6re<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Uzun Vadeli Perspektif<\/td>\n<td>Medikal cihaz yat\u0131r\u0131m\u0131 sab\u0131r gerektirir<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option, Penumbra hisselerini eri\u015filebilir k\u0131lan birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile ger\u00e7ek piyasa maruziyetiyle stratejileri test etmeye ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: 1 dakikal\u0131k KYC s\u00fcreci ile herhangi bir resmi kimlik kullanarak hemen i\u015flem yapabilirsiniz<\/li>\n<li><strong>\u00c7ekim Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>Kesirli Hisseler<\/strong>: PEN gibi premium hisselerde pozisyonlar\u0131 kademeli olarak olu\u015fturmak i\u00e7in ideal<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, b\u00fcy\u00fck sermaye gerektirmeden Penumbra gibi yenilik\u00e7i \u015firketlere yat\u0131r\u0131m yapmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d Penumbra 2025&#8217;te: Medikal Teknoloji Lideri<\/h2>\n<p>Penumbra, inme ve pulmoner emboliye neden olan kan p\u0131ht\u0131lar\u0131n\u0131 \u00e7\u0131karan cihazlarda uzmanla\u015fm\u0131\u015f vask\u00fcler m\u00fcdahale teknolojilerinde \u00f6nc\u00fc konumdad\u0131r. \u015eirketin \u00fcr\u00fcnleri d\u00fcnya \u00e7ap\u0131nda 1.400&#8217;den fazla hastanede kullan\u0131lmakta ve 500.000&#8217;den fazla hastaya tedavi sa\u011flam\u0131\u015ft\u0131r.<\/p>\n<p><strong>Mevcut Pazar Konumu<\/strong>:<\/p>\n<ul>\n<li>Mekanik trombektomi cihazlar\u0131nda lider<\/li>\n<li>1,34 milyar $ y\u0131ll\u0131k gelir h\u0131z\u0131<\/li>\n<li>%66 br\u00fct kar marjlar\u0131 ile fiyatlama g\u00fcc\u00fc<\/li>\n<li>S\u0131f\u0131r bor\u00e7 ve g\u00fc\u00e7l\u00fc nakit pozisyonu<\/li>\n<\/ul>\n<p><strong>2025 \u0130novasyon Odaklar\u0131<\/strong>:<\/p>\n<ul>\n<li>Ruby XL embolizasyon sisteminin geni\u015fletilmesi<\/li>\n<li>VTE (ven\u00f6z tromboembolizm) platform b\u00fcy\u00fcmesi<\/li>\n<li>Uluslararas\u0131 pazar penetrasyonu<\/li>\n<li>Rehber de\u011fi\u015fiklikleri i\u00e7in klinik veri \u00fcretimi<\/li>\n<\/ul>\n<p><strong>\u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: Penumbra&#8217;n\u0131n Lightning Flash\u2122 sistemi, hayat\u0131 tehdit eden kan p\u0131ht\u0131lar\u0131n\u0131 10 dakikadan k\u0131sa s\u00fcrede \u00e7\u0131karabilir &#8211; sabah kahvenizi demlemekten daha h\u0131zl\u0131! Bu zaman kazand\u0131ran \u00f6zellik, acil inme bak\u0131m\u0131nda d\u00fcnya \u00e7ap\u0131nda devrim yarat\u0131yor.<\/p>\n"},"faq":[{"question":"Penumbra, Inc. hisseleri nereden al\u0131nabilir?","answer":"Penumbra, Inc. hisseleri NYSE'de \"PEN\" sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Penumbra hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Bir\u00e7ok platform kesirli hisse al\u0131m\u0131na izin verdi\u011fi i\u00e7in 5 $ gibi d\u00fc\u015f\u00fck tutarlarla bile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"Penumbra'n\u0131n b\u00fcy\u00fcme potansiyeli nedir?","answer":"\u015eirket, yenilik\u00e7i \u00fcr\u00fcn lansmanlar\u0131 ve g\u00fc\u00e7l\u00fc finansal performans\u0131yla 2025-2030 aras\u0131nda %125'in \u00fczerinde uzun vadeli getiri potansiyeline sahiptir."},{"question":"Penumbra hisseleri ne zaman kazan\u00e7 raporu a\u00e7\u0131kl\u0131yor?","answer":"2025 y\u0131l\u0131nda en \u00f6nemli kazan\u00e7 raporu 29 Ekim'de a\u00e7\u0131klanacakt\u0131r. Bu tarihler hisse fiyat\u0131nda \u00f6nemli hareketlere neden olabilir."},{"question":"Penumbra hisseleri yat\u0131r\u0131m riskleri nelerdir?","answer":"FDA onay s\u00fcre\u00e7leri, piyasa volatilitesi, artan rekabet ve i\u00e7erden sat\u0131\u015flar gibi riskler bulunmaktad\u0131r. Ancak \u015firketin g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme ve inovasyon sinyalleri de mevcuttur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Penumbra, Inc. hisseleri nereden al\u0131nabilir?","answer":"Penumbra, Inc. hisseleri NYSE'de \"PEN\" sembol\u00fc ile i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"Penumbra hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Bir\u00e7ok platform kesirli hisse al\u0131m\u0131na izin verdi\u011fi i\u00e7in 5 $ gibi d\u00fc\u015f\u00fck tutarlarla bile yat\u0131r\u0131m yapmaya ba\u015flayabilirsiniz."},{"question":"Penumbra'n\u0131n b\u00fcy\u00fcme potansiyeli nedir?","answer":"\u015eirket, yenilik\u00e7i \u00fcr\u00fcn lansmanlar\u0131 ve g\u00fc\u00e7l\u00fc finansal performans\u0131yla 2025-2030 aras\u0131nda %125'in \u00fczerinde uzun vadeli getiri potansiyeline sahiptir."},{"question":"Penumbra hisseleri ne zaman kazan\u00e7 raporu a\u00e7\u0131kl\u0131yor?","answer":"2025 y\u0131l\u0131nda en \u00f6nemli kazan\u00e7 raporu 29 Ekim'de a\u00e7\u0131klanacakt\u0131r. Bu tarihler hisse fiyat\u0131nda \u00f6nemli hareketlere neden olabilir."},{"question":"Penumbra hisseleri yat\u0131r\u0131m riskleri nelerdir?","answer":"FDA onay s\u00fcre\u00e7leri, piyasa volatilitesi, artan rekabet ve i\u00e7erden sat\u0131\u015flar gibi riskler bulunmaktad\u0131r. Ancak \u015firketin g\u00fc\u00e7l\u00fc b\u00fcy\u00fcme ve inovasyon sinyalleri de mevcuttur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:56:44+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T19:56:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\",\"name\":\"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-25T19:56:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/","og_locale":"tr_TR","og_type":"article","og_title":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:56:44+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T19:56:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/","name":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-25T19:56:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-penumbra\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Penumbra, Inc. (PEN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Penumbra, Inc. (PEN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":350786,"slug":"how-to-buy-penumbra","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Penumbra, Inc. (PEN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Penumbra, Inc. (PEN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-penumbra\/"},"pt_AA":{"locale":"pt_AA","id":350779,"slug":"how-to-buy-penumbra","post_title":"Como comprar a\u00e7\u00f5es da Penumbra, Inc. (PEN) - Investimento em a\u00e7\u00f5es da Penumbra, Inc. (PEN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-penumbra\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=350782"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350782\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=350782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=350782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=350782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}